E. B. Erkhitueva et al. / Tetrahedron Letters 53 (2012) 4304–4308
4307
Table 4
NMR spectral parameters and mass ions in the ESI-MS spectra of compounds 1–10
Compound
NMR spectral parameters: d, ppm (J, Hz)a
C-5 (2JCP C-6 (1JCP
ESI-MS, m/z
C-5-H (3JHP
)
C-2
)
)
C-8 (3JCP
)
P
1
2
3
4
5
6
7
8
9
8.53 (5.6)
8.43 (8.0)
8.36 (8.0)
8.03 (8.0)
8.49 (8.0)
7.93 (8.0)
7.99 (4.0)
7.97 (4.0)
7.45 (8.0)
7.92 (8.0)
161.39
160.92
160.91
150.35
150.38
160.15
158.78
149.71
162.51
158.64
132.28 (21.8)
131.66 (18.1)
131.26 (18.1)
133.15 (17.1)
132.77 (18.1)
125.84 (15.0)
125.67 (14.1)
127.41 (15.1)
125.04 (16.0)
124.61 (15.1)
123.72 (215.2)
124.27 (217.3)
125.24 (218.3)
124.27 (219.3)
125.31 (219.3)
130.43 (187.1)
131.57 (184.8)
130.30 (187.1)
130.84 (193.1)
132.68 (188.1)
155.83 (11.0)
154.98 (12.0)
154.98 (11.0)
154.48 (12.0)
154.55 (11.0)
154.57 (10.0)
154.92 (10.0)
154.06 (9.0)
154.11 (9.0)
154.69 (9.0)
2.68
262.73 [M-Cl]+b
À0.90
À3.90
À1.02
À4.02
À3.92
À4.07
À3.97
À7.81
À6.37
291.0698 [M-Cl]+c
319.2907 [M-Cl]+c
276.0580 [M-Cl]+c
304.0894 [M-Cl]+c
249.0226 [M+H]+c
363.0314 [M+Na]+c
234.0124 [M+H]+c
263.0415 [M+H]+c
326.75 [M]+b
10
a
b
c
Bruker Avance 400, 400.13 MHz (1H), 100.61 MHz (13C), 161.98 MHz (31P), 40.54 MHz (15N), solvents D2O and DMSO-d6.
TSQ Quantum Access MAX.
Bruker micrOTOF.
2001, 424–428; (c) Yu, H.-X.; Ma, J.-F.; Xu, G.-H.; Li, S.-L.; Yang, J.; Liu, Y.-Y.;
Cheng, Y.-X. J. Organomet. Chem. 2006, 691, 3531–3539; (d) Smicius, R.;
Burbuliene, M. M.; Jakubkiene, V.; Udrenaite, E.; Vainilavicius, P. J. Heterocycl.
Chem. 2007, 44, 279–284; (e) Aytac, S. P.; Tozkoparan, B.; Kaynak, F. B.; Aktay,
G.; Goektas, O.; Uenuevar, S. Eur. J. Med. Chem. 2009, 44, 4528–4538; (f) Kaynak,
F. B.; Aytac, S. P.; Tozkoparan, B. Struct. Chem. 2010, 21, 795–802.
carbonate, or in a protic solvent (methanol or acetonitrile-metha-
nol mixture), or using potassium triazolothiolate, resulted in diffi-
cult to separate mixtures that included, in addition to the
thiazolotriazolium derivatives, compounds containing, by NMR
spectroscopy, PCH@ and PCH2 groups, as well as other substances.
Obviously, in these cases, parallel reactions proceed with attack of
both nucleophilic sites on the haloacetylenic carbon atom. In the
presence of a proton-donor (solvent) or a base (potassium thio-
late), the sulfenium cation was not formed or was rapidly con-
verted into a sulfide group, which exhibited an electron-donor
effect causing a change in the reaction regioselectivity.
6. Erkhitueva, E. B.; Dogadina, A. V.; Khramchikhin, A. V.; Ionin, B. I. Russ. J. Gen.
Chem. 2011, 81, 2377–2378. Zh. Obsch. Khim. 2011, 81, 1925–1926.
7. Typical experimental procedure for the synthesis of compounds 1–5 and 6–8. To a
solution of 5 mmol of
anhydrous MeCN under vigorous stirring at room temperature was added
5 mmol of 4-amino(methyl)-3-thiolo-5-alkyl(aryl)-1,2,4-triazole. The
a dialkyl chloroacetylenephosphonate in 10 ml of
suspension was stirred vigorously at room temperature for 3–15 h. The
resulting precipitate was filtered and washed with Et2O to afford the
thiazolotriazolium salt 1–5 (see Table 2). The solvent was removed from the
filtrate under vacuum, and the viscous crystalline residue was recrystallized
from a mixture of MeOH–2-propanol (1:1). The resulting crystals were the
corresponding zwitterions 6–8 (see Table 3). The zwitterions with ethoxy- and
isopropoxyphosphoryl groups (not considered in this Letter) can be obtained
from the corresponding thiazolotriazolium salts by heating in EtOH or H2O for
2–3 h at 70–80 °C. 3-Amino-6-(dimethoxyphosphoryl)-2-methyl-3H-thiazolo[3,2-
b][1,2,4]triazol-7-ylium chloride (1). IR (KBr, cmÀ1): 567, 617, 702, 760, 818, 845,
968, 1049, 1192, 1238, 1269, 1373, 1404, 1524, 1558, 1651, 2951, 3013, 3121.
1H NMR (400.13 MHz, D2O): d 2.72 (s, 3H, CH3), 3.94 (d, 3JHP 11.6 Hz, 6H, OCH3),
Acknowledgements
The authors would like to thank Valentin I. Zakharov PhD (SPb-
STI; the Department of Organic Chemistry; Laboratory NMR) for
NMR spectral analyses and Konstantin Lysenko (INEOS, Laboratory
for X-Ray Diffraction Studies) for XRD data.
3
8.53 (d, JHP 5.6 Hz, 1H, H-ring). 13C NMR (100.61 MHz, D2O): d 10.10 (s, CH3),
55.55 (d, 2JCP 6.0 Hz, OCH3), 123.72 (d, 1JCP 215.2 Hz, C6), 132.28 (d, 2JCP 21.8 Hz,
Supplementary data
3
C5), 155.83 (d, JCP 11.0 Hz, C8), 161.39 (s, C2). 31P NMR (161.98 MHz, D2O): d
2.68. ESI-MS: calcd for C7H12ClN4O3PS: 298.6869; found: 262.73 (M-Cl)+. 3-
Amino-6-(diethoxyphosphoryl)-2-methyl-3H-thiazolo[3,2-b][1,2,4]triazol-7-ylium
chloride (2). IR (KBr, cmÀ1): 542.9, 580, 761, 970, 1004, 1089, 1066, 1239, 1264,
1298, 1398, 1442, 1558, 1634, 2938, 2990, 3095, 3186. 1H NMR (400.13 MHz,
Supplementary data associated with this article can be found, in
the
online
version,
at
3
3
D2O): d 1.30 (t, JHH 8.0 Hz, 6H, OCH2CH33), 2.67 (s, 3H, CH3), 4.29 (dq, JHH
8.0 Hz, JHP 12.0 Hz, 4H, OCH2), 8.43 (d, JHP3 8.0 Hz, 1H, H-ring). 13C NMR
3
(100.61 MHz, D2O): d 9.83 (s, CH3), 15.51 (d, JCP 6.0 Hz, OCH2CH3), 66.33 (d,
References and notes
2JCP 6.0 Hz, OCH2), 124.27 (d, JCP 217.3 Hz, C6), 131.66 (d, JCP 18.1 Hz, C5),
154.98 (d, 3JCP 12.0 Hz, C8), 160.92 (s, C2). 31P NMR (161.98 MHz, D2O): d À0.90.
ESI-MS: calcd for C9H16ClN4O3PS: 326.7401; found: 291.0698 (M-Cl)+. 3-
Methyl-6-(diethoxyphosphoryl)-3H-thiazolo[3,2-b][1,2,4]triazol-7-ylium chloride
(4). IR (KBr, cmÀ1): 557, 574, 795, 936, 984, 1016, 1043, 1069, 1164, 1253,
1269, 1299, 1454, 1567, 1835, 2910, 2995, 3116. 1H NMR (400.13 MHz, D2O): d
1
2
1. (a) Sahoo, P. K.; Pattanayak, P. Med. Chem. Res. 2010, 19, 127–135; (b) Hassan,
A.; Thomas, N. F.; Gapil, Sh. Molecules 2011, 16, 1297–1309; (c) Hassan, A. Y.
Phosphorus, Sulfur Silicon 2009, 184, 2759–2776; (d) Heravi, M. M.;
Rahimizaden, M.; Seyf, M.; Davoodnia, A.; Ghassemzaden, M. Phosphorus,
Sulfur Silicon. 2000, 167, 211–217; (e) El-Sherif, H. A. H.; Mahmoud, A. M.;
Sarhan, A. A. O.; Hozien, Z. A.; Habib, O. M. A. J. Sulfur Chem. 2006, 27, 65–85.
2. (a) Nakhmanovich, A. S.; Elokhina, V. N.; Karnaukhova, R. V.; Skvortsova, G. G.;
Kalikhman, I. D. Chem. Heterocycl. Comp. 1982, 18, 1154–1156. Khim. Geterotsikl.
Soed. 1982, 18, 1489–1491; (b) Nakhmanovich, A. S.; Komarova, T. N.;
Mansurov, Y. A. Bull. Acad. Sci. USSR 1984, 33, 1077–1078. Izv. Akad. Nauk
SSSR. 1984, 5, 1173–1175; (c) Garibina, V. A.; Leonov, A. A.; Dogadina, A. V.;
Ionin, B. I.; Petrov, A. A. J. Gen. Chem. (Engl. Transl.) 1985, 55, 1771–1781. Zh.
Obsch. Khim. 1985, 55, 1994–2006; (d) Garibina, V. A.; Leonov, A. A.; Dogadina,
A. V.; Ionin, B. I.; Petrov, A. A. J. Gen. Chem. (Engl. Transl.) 1987, 57, 1321–1327.
Zh. Obsch. Khim. 1987, 57, 1481–1488; (e) Stepanova, N. P.; Orlova, N. A.;
Turbanova, E. S.; Petrov, A. A. J. Org. Chem. USSR (Engl. Transl.) 1986, 22, 388–
389. Zh. Org. Khim. 1986, 22, 439–440; (f) Tikhomirov, D. A.; Slyadevskaya, O. S.;
Eremeev, A. V. Chem. Heterocycl. Comp. 1991, 27, 966–969. Khim. Geterotsikl.
Soed. 1991, 27, 1205–1208.
3
3
3
1.32 (t, JHH 8.0 Hz, 6H, CH3), 4.10 (s, 3H, NCH3), 4.32 (dq, JHH 8.0 Hz, JHP
12.0 Hz, 4H, OCH2), 8.03 (d, JHP 8.0 Hz, 1H, H-ring), 9.07 (s, 1H, N@CH). 13C
3
3
NMR (100.61 MHz, D2O): d 15.53 (d, JCP 6.0 Hz, OCH2CH3), 34.72 (s, NCH3),
66.45 (d, 2JCP 6.0 Hz, OCH2), 124.27 (d, 1JCP 219.3 Hz, C6), 133.15 (d, 2JCP 17.1 Hz,
C5), 150.35 (s, C2), 154.48 (d, JCP 12.0 Hz, C8). 31P NMR (161.98 MHz, D2O): d
3
À1.02. ESI-MS: calcd for C9H15ClN3O3PS: 311.7254; found: 276.0580 (M-Cl)+.
Methyl
3-amino-2-methyl-3H-thiazolo[3,2-b][1,2,4]triazol-7-ylium-6-
phosphonate (6). IR (KBr, cmÀ1): 548, 555, 586, 762, 962, 1044, 1099, 1106,
1182, 1251, 1651, 1670, 3107, 3259, 3378, 3401. 1H NMR (400.13 MHz, D2O): d
3
3
2.63 (s, 3H, CH3), 3.52 (d, JHP 12.0 Hz, 3H, OCH3), 7.93 (d, JHP 8.0 Hz, 1H, H-
ring). 13C NMR (100.61 MHz, D2O): d 9.77 (s, CH3), 52.91 (d, 2JCP 6.0 Hz, OCH3),
125.84 (d, 2JCP 15.0 Hz, C5), 130.43 (d, 1JCP 187.1 Hz, C6), 154.57 (d, 3JCP 10.0 Hz,
C8), 160.15 (s, C2). 15N NMR (40.54 MHz, D2O): d 66.06 (s, NH2), 173.43 (s, N3),
232.84 (d, 2JNP 6.6 Hz, N7), 269.09 (s, N1). 31P NMR (161.98 MHz, D2O): d À3.92.
ESI-MS: calcd for C6H9N4O3PS: 248.1994; found: 249.0226 (M+H)+.
3. (a) Fan, X.; He, Y.; Zhang, X.; Guo, S.; Wang, Y. Tetrahedron 2011, 67, 6369–
6374; (b) Zhang, M.-T.; Irebo, T.; Johansson, O.; Hammarstroem, L. J. Am. Chem.
Soc. 2011, 133, 13224–13227; (c) Shen, W.; Kohn, T.; Fu, Z.; Jiao, X. Y.; Lai, S.;
Schmitt, M. Tetrahedron Lett. 2008, 49, 7284–7286.
4. Glotova, T. E.; Nakhmanovich, A. S.; Sigalov, M. V. J. Org. Chem. USSR (Engl.
Transl.) 1988, 24, 1941–1945. Zh. Org. Khim. 1988, 24, 2151–2156.
8. The X-ray crystal structure for compound
1 has been deposited at the
Cambridge Crystallographic Data Centre and allocated the deposition number
CCDC 848044. Formula: C7H12ClN4O3PS. Crystal system monoclinic, space
group P2(1)/c. Unit cell parameters: a = 15.3837(11) Å, b = 6.0034(4) Å,
c = 14.5397(10) Å,
T = 100(2) K; Z = 4;
a
= 90°, b = 110.5360(10)°,
c
= 90°. V = 1257.47(15) Å3;
q
calc = 1.578 Mg/m3; = 0.599 mmÀ1 (for MoK
l a,
5. (a) Beyer, H.; Kroege, C.-F. Liebigs Ann. Chem. 1960, 637, 135–145; (b)
Cartwright, D. D. J.; Clark, B. A. J.; McNab, H. J. Chem. Soc., Perkin Trans. 1
k = 0.71073 Å); F(000) = 616; full-matrix least-squares on F2; data = 3710;
parameters = 157; restraints = 0; wR(all) = 0.0837; GoF(all) = 1.034.